Find and Pitch Jounalists, Get Your Story Covered

Tags: selenium gastric bypass endocrinology remission weight loss

	Profile	Recent Articles on Subject
1	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Novel Agent Reduces Monthly Migraine Days - 15 days ago BTK Inhibitor Reduces Brain Lesions in Relapsing MS - 11 months ago
2	John Gever MedPage Today MedPage Today factotum. Pittsburgh, Pa. Healthcare journalism	Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus - 15 days ago Another Study Backs Treatment for Preclinical Rheumatoid Arthritis - 7 months ago
3	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers - 15 days ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 7 months ago Novel Therapy Promising for Radiation-Induced Oral Mucositis - 7 months ago Vaccine 'Promising' for Delaying Relapse in KRAS-Mutated Pancreatic Cancer, CRC - 8 months ago Axatilimab Shows Efficacy in Recurrent/Refractory GVHD - 9 months ago Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS - 10 months ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - 11 months ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - 11 months ago
4	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	RHB-104 Plus Standard of Care Offers Extended Treatment for Crohn Disease - about 1 month ago Dramatic Tumor Regression Was Displayed in New Approach to CAR T Therapy - 6 months ago FDA Approves Ravulizumab-cwvz for Neuromyelitis Optica Spectrum Disorder - 6 months ago FDA Grants Breakthrough Device Designation for Neuroimmune Modulation Platform To Treat MS - 6 months ago Researchers Announce Positive Trial Data for the Use of Remibrutinib In Chronic Spontaneous Urticaria - 10 months ago Treatment With Anifrolumab-fnia Shows Promising Rates of Remission for Lupus - 11 months ago Esketamine in Combination with Oral Antidepressant Could Aid Treatment-Resistant Depression - 12 months ago Study Finds Obesity Remission Rates Are Lower Than Overweight Remission Rates in Children - 12 months ago
5	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma - 3 months ago Positive Results for Odronextamab in Relapsed/Refractory DLBCL - 9 months ago "I'm Doing Great, So When Can I Stop My Atopic Dermatitis Treatment?" - 10 months ago A Novel Mechanism of Action in Treating Relapsing MS - 10 months ago New Guselkumab Responses in Ulcerative Colitis Emerge After 12 Weeks - 10 months ago New Data on CD40 Ligand Inhibitor for Relapsing MS - 10 months ago Multiple Sclerosis: Paving the Way to a Cure - 11 months ago MS Treatment-Discontinuation Study Terminated After Disease Activity Returns - 11 months ago
6	Kristen Monaco MedPage Today	Antidepressant Discontinuation; Gun Suicide Prevention; REM Disorder Breakthrough - 3 months ago FDA Approves First-Ever Drug for Serious Liver Condition - 6 months ago T2D Remission Common With Gastric Bypass; Selenium for Hashimoto's; Cereal Chemicals - 7 months ago
7	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Relapsed/Refractory Multiple Myeloma Treatment Advances With Three BiTE Therapy Options - 6 months ago Ibrutinib Plus Venetoclax With MRD-Directed Duration of Treatment Is a New Standard of Care Regimen for Previously Untreated CLL - 9 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Study: Only 40% of Adults With Childhood Asthma Experience Remission - 6 months ago Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma - 10 months ago Subcutaneous Lecanemab Demonstrates Greater Amyloid Plaque Removal Than Intravenous Lecanemab - 11 months ago
9	Erin Hunter, Associate Editor Pharmacy Times Actor-writer. Nominated BBC Popcorn. London, United Kingdom actingwritingcomedy	Risankizumab Significantly Reduces Severity of Psoriasis Symptoms - 6 months ago
10	Adam Feuerstein STAT News Reporter at STATnews. Dog lover. Polk Award winner. Boston, Massachusetts biotech reporting	STAT+: Madrigal wins first U.S. approval for drug to treat liver disease MASH - 6 months ago STAT+: First medicine developed to treat MASH expected to be approved soon - 6 months ago

Journalists covering remission